NILS LONBERG
CIK 1214506 · Sr. VP, Scientific Director · last filed 2025-06-10
NILS LONBERG is a Sr. VP, Scientific Director who has filed 12 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for BCAX, was dated Jun 10, 2025. Across all open-market trades the lifetime net is −$245.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
12
-$245.5K
Holdings By Company
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-10 | BCAX | Grant (A) | — | $0 | EDGAR |
| 2024-09-16 | BCAX | Grant (A) | — | $0 | EDGAR |
| 2009-09-03 | — | Disp (D) | — | $0 | |
| 2009-08-31 | MEDX | U | −134,550 | -$2.15M | EDGAR |
| 2009-04-06 | MEDX | Sell (S) | −10,750 | -$55.9K | EDGAR |
| 2009-03-06 | MEDX | Grant (A) | — | $0 | EDGAR |
| 2009-02-26 | MEDX | Mixed | — | -$68.6K | EDGAR |
| 2008-03-04 | MEDX | Grant (A) | — | $0 | EDGAR |
| 2007-10-02 | MEDX | Exer (M) | +30,000 | $81.6K | EDGAR |
| 2007-05-18 | MEDX | Grant (A) | — | $0 | EDGAR |